Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012-2018.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 15 2 2020
pubmed: 15 2 2020
medline: 24 10 2020
Statut: ppublish

Résumé

To evaluate the impact of sepsis, age, and comorbidities on death following an acute inpatient admission and to model and forecast inpatient and skilled nursing facility costs for Medicare beneficiaries during and subsequent to an acute inpatient sepsis admission. Analysis of paid Medicare claims via the Centers for Medicare & Medicaid Services DataLink Project (CMS) and leveraging the CMS-Hierarchical Condition Category risk adjustment model. All U.S. acute care hospitals, excepting federal hospitals (Veterans Administration and Defense Health Agency). All Part A/B (fee-for-service) Medicare beneficiaries with an acute inpatient admission in 2017 and who had no inpatient sepsis admission in the prior year. None. Logistic regression models to determine covariate risk contribution to death following an acute inpatient admission; conventional regression to predict Medicare beneficiary sepsis costs. Using the Hierarchical Condition Category risk adjustment model to illuminate influence of illness on outcome of inpatient admissions, representative odds ratios (with 95% CIs) for death within 6 months of an admission (referenced to beneficiaries admitted but without the characteristic) are as follows: septic shock, 7.27 (7.19-7.35); metastatic cancer and acute leukemia (Hierarchical Condition Category 8), 6.76 (6.71-6.82); all sepsis, 2.63 (2.62-2.65); respiratory arrest (Hierarchical Condition Category 83), 2.55 (2.35-2.77); end-stage liver disease (Hierarchical Condition Category 27), 2.53 (2.49-2.56); and severe sepsis without shock, 2.48 (2.45-2.51). Models of the cost of sepsis care for Medicare beneficiaries forecast arise approximately 13% over 2 years owing the rising enrollments in Medicare offset by the cost of care per admission. A sepsis inpatient admission is associated with marked increase in risk of death that is comparable to the risks associated with inpatient admissions for other common and serious chronic illnesses. The aggregate costs of sepsis care for Medicare beneficiaries will continue to increase.

Identifiants

pubmed: 32058368
doi: 10.1097/CCM.0000000000004225
pii: 00003246-202003000-00004
pmc: PMC7017950
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

302-318

Commentaires et corrections

Type : CommentIn

Références

Crit Care Med. 2020 Mar;48(3):289-301
pubmed: 32058367
Influenza Other Respir Viruses. 2018 Jan;12(1):132-137
pubmed: 29446233
PLoS One. 2018 Mar 20;13(3):e0194371
pubmed: 29558486
Crit Care. 2019 May 31;23(1):196
pubmed: 31151462
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):634-642
pubmed: 29879098
Crit Care. 2018 Sep 23;22(1):232
pubmed: 30243300
BMJ. 2014 Jan 24;348:f7450
pubmed: 24464277
JAMA. 2014 Apr 2;311(13):1308-16
pubmed: 24638143
Crit Care Med. 2013 May;41(5):1167-74
pubmed: 23442987
Crit Care Med. 2020 Mar;48(3):276-288
pubmed: 32058366

Auteurs

Timothy G Buchman (TG)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.
Emory Critical Care Center, Emory University, Atlanta, GA.

Steven Q Simpson (SQ)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas, Kansas City, KS.

Kimberly L Sciarretta (KL)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Kristen P Finne (KP)

Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.

Nicole Sowers (N)

Acumen, LLC, Burlingame, CA.

Michael Collier (M)

Acumen, LLC, Burlingame, CA.

Saurabh Chavan (S)

Acumen, LLC, Burlingame, CA.

Ibijoke Oke (I)

Acumen, LLC, Burlingame, CA.

Meghan E Pennini (ME)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Aathira Santhosh (A)

Acumen, LLC, Burlingame, CA.

Marie Wax (M)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Robyn Woodbury (R)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Steve Chu (S)

Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD.

Tyler G Merkeley (TG)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Gary L Disbrow (GL)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Rick A Bright (RA)

Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.

Thomas E MaCurdy (TE)

Acumen, LLC, Burlingame, CA.
Department of Economics, Stanford University, Stanford, CA.
Hoover Institution, Stanford University, Stanford, CA.
Stanford Institute for Economic Policy Research, Stanford University, Stanford, CA.

Jeffrey A Kelman (JA)

Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH